» Articles » PMID: 17192164

Therapeutic Options for Sleep-maintenance and Sleep-onset Insomnia

Overview
Journal Pharmacotherapy
Specialty Pharmacology
Date 2006 Dec 29
PMID 17192164
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Insomnia, defined as difficulty falling asleep, staying asleep, and/or experiencing restorative sleep with associated impairment or significant distress, is a common condition resulting in significant clinical and economic consequences. Many options are available to treat insomnia, to assist with either falling asleep (sleep onset) or maintaining sleep. We searched MEDLINE for articles published between January 1996 and January 2006, evaluated abstracts from recent professional meetings, and contacted the manufacturer of the most recent addition to the pharmacologic armamentarium for insomnia treatment (ramelteon) to gather information. Nonpharmacologic options include stimulus control, sleep hygiene education, sleep restriction, paradoxical intention, relaxation therapy, biofeedback, and cognitive behavioral therapy. Prescription and over-the-counter drug therapies include benzodiazepine and nonbenzodiazepine sedative-hypnotic agents; ramelteon, a melatonin receptor agonist; trazodone; and sedating antihistamines. Herbal and alternative preparations include melatonin and valerian. Before recommending any treatment, clinicians should consider patient-specific criteria such as age, medical history, and other drug use, as well as the underlying cause of the sleep disturbance. All pharmacotherapy should be used with appropriate caution, at minimum effective doses, and for minimum duration of time.

Citing Articles

Central amygdala somatostatin neurons modulate stress-induced sleep-onset insomnia.

Yao W, Huang S, Zhang L, Li Z, Huang D, Huang K Commun Biol. 2025; 8(1):381.

PMID: 40050691 PMC: 11885604. DOI: 10.1038/s42003-025-07679-8.


The significance of chirality in contemporary drug discovery-a mini review.

Senkuttuvan N, Komarasamy B, Krishnamoorthy R, Sarkar S, Dhanasekaran S, Anaikutti P RSC Adv. 2024; 14(45):33429-33448.

PMID: 39439836 PMC: 11495282. DOI: 10.1039/d4ra05694a.


Effect of graduated drug therapy for moderate-to-severe chronic insomnia on the severity of disease: an observational study in Germany.

Boer J, Toncar T, Stange A, Rosenblum L, Fietze I J Clin Sleep Med. 2024; 21(1):33-45.

PMID: 39172069 PMC: 11701294. DOI: 10.5664/jcsm.11334.


The role of arts therapies in mitigating Sleep Initiation and Maintenance Disorders: a systematic review.

Luo X, Zhang A, Li H, Li Y, Ying F, Wang X Front Psychiatry. 2024; 15:1386529.

PMID: 38818021 PMC: 11137235. DOI: 10.3389/fpsyt.2024.1386529.


Investigating the Efficacy of Theta Binaural Beat on the Absolute Power of Theta Activity in Primary Insomniacs.

Bavafa A, Foroughi A, Jaberghaderi N, Khazaei H Basic Clin Neurosci. 2023; 14(3):331-340.

PMID: 38077174 PMC: 10700810. DOI: 10.32598/bcn.2021.2162.1.